These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30457913)

  • 1. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
    Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
    Chalasani N; Vuppalanchi R; Raikwar NS; Deeg MA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2279-85. PubMed ID: 16595594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
    Bowen RF; Raikwar NS; Olson LK; Deeg MA
    Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.
    Ter Horst KW; Gilijamse PW; Versteeg RI; Ackermans MT; Nederveen AJ; la Fleur SE; Romijn JA; Nieuwdorp M; Zhang D; Samuel VT; Vatner DF; Petersen KF; Shulman GI; Serlie MJ
    Cell Rep; 2017 Jun; 19(10):1997-2004. PubMed ID: 28591572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
    Jani S; Da Eira D; Stefanovic M; Ceddia RB
    J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism.
    Chalhoub G; Jamnik A; Pajed L; Kolleritsch S; Hois V; Bagaric A; Prem D; Tilp A; Kolb D; Wolinski H; Taschler U; Züllig T; Rechberger GN; Fuchs C; Trauner M; Schoiswohl G; Haemmerle G
    Mol Metab; 2023 Jun; 72():101725. PubMed ID: 37059417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
    Andrés-Blasco I; Herrero-Cervera A; Vinué Á; Martínez-Hervás S; Piqueras L; Sanz MJ; Burks DJ; González-Navarro H
    J Endocrinol; 2015 Dec; 227(3):179-91. PubMed ID: 26423094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
    Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
    Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance.
    Raikwar NS; Bowen-Deeg RF; Du XS; Low MG; Deeg MA
    Metabolism; 2010 Oct; 59(10):1413-20. PubMed ID: 20153004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
    Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
    Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.
    Qiu Y; Sui X; Zhan Y; Xu C; Li X; Ning Y; Zhi X; Yin L
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):978-990. PubMed ID: 28153708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
    Raikwar NS; Cho WK; Bowen RF; Deeg MA
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.
    Cantley JL; Yoshimura T; Camporez JP; Zhang D; Jornayvaz FR; Kumashiro N; Guebre-Egziabher F; Jurczak MJ; Kahn M; Guigni BA; Serr J; Hankin J; Murphy RC; Cline GW; Bhanot S; Manchem VP; Brown JM; Samuel VT; Shulman GI
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1869-74. PubMed ID: 23302688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.
    Petersen MC; Madiraju AK; Gassaway BM; Marcel M; Nasiri AR; Butrico G; Marcucci MJ; Zhang D; Abulizi A; Zhang XM; Philbrick W; Hubbard SR; Jurczak MJ; Samuel VT; Rinehart J; Shulman GI
    J Clin Invest; 2016 Nov; 126(11):4361-4371. PubMed ID: 27760050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.